McKesson Corporation
McKesson Launches InspiroGene a Dedicated Business to Guide and Support the Commercialization of Cell and Gene Therapies
IRVING, Texas, October 1, 2024 - McKesson Corporation today announced the launch of InspiroGene TM by McKesson ("InspiroGene"), a dedicated business focused solely on supporting the commercialization of cell and gene therapies (CGTs). With a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and provide ...
